Clinical effectand safety of low dose Mirtazapine combined with Duloxetine in the treatment of senile refractory depression
JIANG Shen-hui YE Qing
1.Department of Clinical Laboratory,the Fourth People′s Hospital of Jingdezhen City in Jiangxi Province,Jingdezhen 333000,China;
2.Department of Psychiatic,the Fourth People′s Hospital of Jingdezhen City in Jiangxi Province,Jingdezhen 333000,China
Abstract:ObjectiveTo investigate the clinical effect and safety of low dose Mirtazapine combined with Duloxetine in the treatment of senile refractory depression.Methods88 elderly patients with refractory depression in our hospital during the period from May 2015 to August 2016 were selected,and randomly divided into two groups according to the random number table method,the observation group (44 cases)and control group (44 cases).The control group were treated with Duloxetine treatment,the observation group were treated with small dose of Mirtazapine on the basis of control group,patients of two group were treated for two months.The scores of anxiety and depression,the clinical effect and adverse reactions were compared.ResultsThe scores of HAMA,HAMD and CGI-SI in the observation group were significantly lower than those in the control group after 2 weeks,5 weeks and 7 weeks,the difference was statistically significant(P<0.05).The TESS score of the observation group was(1.78±0.36)points,compared with the control group[(1.86±0.47)points],there was no statistically significant difference (P>0.05).The incidence of adverse reactions in observation group was 4.55%,compared with the control group 6.82%,showed no significant difference (P>0.05).The total effective rate in the observation group was 93.18%,significantly higher than the control group(72.72%),the difference was statistically significant(P<0.05).ConclusionFor elderly refractory depression patients,the combination of low-dose Mirtazapine and Duloxetine can achieve better therapeutic effect,and will not increase the incidence of adverse drug reactions.It is worth popularizing.